
11 - 50 employees
Founded 2017
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Akero Therapeutics is a company pioneering novel therapies to transform the lives of people living with serious metabolic diseases. Their flagship program, Efruxifermin (EFX), is aimed at treating metabolic dysfunction-associated steatohepatitis (MASH) and is currently undergoing multiple clinical trials. Akero is committed to advancing medicine in the field of metabolic diseases and has a strong focus on research, development, and clinical studies.
🕒 4 days ago
Clinical TMF Operations Administrator contributing to Phase 3 clinical development program for Efruxifermin at Akero Therapeutics. Leading TMF operations and ensuring compliance and quality oversight.
🇺🇸 United States – Remote
💵 $99.6k - $155.4k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
🏥 Clinical Operations
🕒 July 10
Senior Director, Clinical Data Management leading clinical data management for drug development at Akero Therapeutics. Overseeing clinical data, collaborating with cross-functional teams, and mentoring data management professionals.